$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
靶向药吉非替尼可以长期服用吗?
2025-10-19 11:44:20
Check Details
肺癌靶向药吉非替尼进医保了吗?
2025-10-19 11:44:20
Check Details
肺癌靶向治疗药物吉非替尼说明书
2025-10-19 11:44:20
Check Details
吉非替尼对肺癌的效果
2025-10-19 11:44:20
Check Details
用吉非替尼治疗期间不能吃什么?
2025-10-19 11:44:20
Check Details
肺癌靶向药吉非替尼耐药后要怎么处理?
2025-10-19 11:44:20
Check Details
吉非替尼(易瑞沙)适用于什么病症?
2025-10-19 11:44:20
Check Details
肺癌治疗用药吉非替尼效果如何?
2025-10-19 11:44:20
Check Details
肺癌靶向药吉非替尼(易瑞沙)服用方法
2025-10-19 11:44:20
Check Details
广谱靶向抗癌药拉罗替尼去哪买?
2025-10-19 11:44:20
Check Details
非小细胞肺癌的靶向治疗药物雷莫芦单抗
2025-10-19 11:44:20
Check Details
抗肺癌新药劳拉替尼国内上市了吗?
2025-10-19 11:44:20
Check Details
1
2
...
9722
9723
9724
9725
9726
9727
9728
...
10205
10206
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
RAS Targeted Therapy Resistance Breakthrough: mTORC1 is Key, Dalifarnib Combination Therapy Brings Hope
2
ARID1A Gene: A New Breakthrough in Tumor Immunotherapy, Turning "Cold Tumors" Hot
3
Alectinib for ALK-Positive Lung Cancer: Efficacy, Side Effects & Clinical Outlook
4
Mavacamten (Maifantuo): A Targeted Therapy for Obstructive Hypertrophic Cardiomyopathy
5
Remibrutinib (Ruipoduo): Safety, Side Effects, and Usage Guidelines
6
Which Generation TKI Is Repotrectinib? Professional Analysis of Next-Gen ROS1 Inhibitor Classification and Clinical Features
7
Brigatinib for NF2 Neurofibromatosis: Mechanism, Efficacy and Prospects
8
Dietary Guide During Goserelin Treatment: Scientific Nutrition Management to Alleviate Side Effects and Improve Quality of Life.
9
CYP26A1 Gene Emerges as New Target for Colorectal Cancer Treatment! Folate Metabolism Research Brings Hope for Immunotherapy.
10
Precision Breakthrough: Inavolisib Redefines Survival in PIK3CA-Mutant Breast Cancer
11
Romiplostim vs. Eltrombopag: ITP Treatment Dosing Differences and Precision Selection
12
Asciminib: Mechanism and Clinical Value of the First ABL Allosteric Inhibitor